Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

PR Newswire
December 6, 2023 — 08:16 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America army Casino China chinese Economy healthcare Hong Kong JD finance Macau manufacturing medicine military PLA statistics stock market Suzhou taiwan United States

Related News:

Supermicro Begins Volume Shipments of Max-Performance Servers Optimized for AI, HPC, Virtualization, and Edge Workloads

January 9, 2025 — 22:05

BICV’s Debut at CES 2025: Showcasing Full-Stack, All-Domain Products on the International Stage

January 9, 2025 — 22:03

MANTRA and DAMAC Group Revolutionize Tokenized Real-World Assets with US$1 Billion Deal

January 9, 2025 — 22:00

JSAUX Debuts at CES 2025, Showcases Innovative FlipGo Portable Monitor

January 5, 2025 — 12:00

Evolving Global Asset Management Industry in Focus at Asset Abu Dhabi

December 11, 2024 — 02:10

Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

November 8, 2024 — 17:45

LPS Launches NeuroNode: Empowering Advanced AI for Enterprises with On-Premises LLM

November 7, 2024 — 17:39

Cybellum Receives Frost & Sullivan’s Competitive Strategy Award for its Innovative Product Security Solutions

September 27, 2024 — 01:00

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

September 14, 2024 — 08:18

Franchising and Licensing Asia (FLAsia) 2024